NCT07274813 2026-03-03
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase EARLY_PHASE1 Recruiting
Clinical Trials
12 trialsNCT05645523 2026-02-25
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07412665 2026-02-17
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Not yet recruiting
NCT07220447 2026-02-12
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
City of Hope Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06824155 2026-02-11
RAD202
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT04733027 2026-01-22
Clever Peptide
Institut Curie
Phase EARLY_PHASE1 Active not recruiting
NCT07349160 2026-01-16
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT05245682 2026-01-08
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Emory University
Phase EARLY_PHASE1 Active not recruiting
NCT07325123 2026-01-08
Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors
The First Affiliated Hospital of Xinxiang Medical College
Phase EARLY_PHASE1 Not yet recruiting
NCT05868486 2026-01-02
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
City of Hope Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT06380309 2025-12-23
A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
Peking University
Phase EARLY_PHASE1 Recruiting